| Role of mitochondrial aldehyde dehydrogenase in nitroglycerin-induced vasodilation of coronary and systemic vessels: an intact canine model. | |
| | |
MedLine Citation:
|
PMID: 15289380 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: It has recently been shown that mitochondrial aldehyde dehydrogenase 2 (mtALDH) catalyzes the formation of 1,2-glyceryl dinitrate and nitrite from nitroglycerin (glyceryl trinitrate [GTN]) within mitochondria, leading to production of cGMP and vasorelaxation. However, whether this mechanism operates in the systemic and coronary beds that subserve the antianginal action of GTN is not known. In this study, we address this question in an intact canine model. METHODS AND RESULTS: Fourteen healthy mongrel dogs (weight, 20 to 25 kg) were studied. Coronary blood flow and hemodynamics were continuously monitored by a pulse Doppler flow probe implanted around the left circumflex coronary artery and with catheters in left ventricle and aorta, respectively. Each dog was given a 1-mL bolus injection of GTN, sodium nitroprusside (SNP), or adenosine through a catheter in the left atrium before and 30 minutes after infusion of cyanamide (17 mg/kg), an inhibitor of mtALDH. Cyanamide significantly inhibited both the classic dehydrogenase and GTN reductase activities of mtALDH in situ and attenuated the coronary blood flow increase and declines in blood pressure and left ventricular end-diastolic pressure produced by GTN in vivo. In contrast, mtALDH inhibition had no effect on the coronary and systemic effects of SNP and adenosine. CONCLUSIONS: Our data suggest that mtALDH contributes to GTN biotransformation in vivo and thus at least partly underlies the antianginal mechanism of drug action. Our findings also highlight the differences in biometabolism of clinically relevant nitrosovasodilators. |
| | |
Authors:
|
Jian Zhang; Zhiqiang Chen; Frederick R Cobb; Jonathan S Stamler |
Publication Detail:
|
Type: Journal Article Date: 2004-08-02 |
Journal Detail:
|
Title: Circulation Volume: 110 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2004 Aug |
Date Detail:
|
Created Date: 2004-08-10 Completed Date: 2005-02-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 750-5 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenosine
/
pharmacology Aldehyde Dehydrogenase / physiology* Animals Biotransformation / drug effects Blood Pressure / drug effects Coronary Circulation / drug effects* Cyanamide / pharmacology Cyclic GMP / biosynthesis Diastole Dogs Mitochondria / enzymology* Nitrites / metabolism Nitroglycerin / analogs & derivatives*, metabolism, pharmacokinetics* Nitroprusside / pharmacology Vasodilation / drug effects*, physiology |
| Chemical | |
Reg. No./Substance:
|
0/Nitrites; 15078-28-1/Nitroprusside; 27321-62-6/dinitroglycerol; 420-04-2/Cyanamide; 55-63-0/Nitroglycerin; 58-61-7/Adenosine; 7665-99-8/Cyclic GMP; EC 1.2.1.3/Aldehyde Dehydrogenase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
Next Document: Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure ...